ClinicalTrials.Veeva

Menu

Ambu AuraOnce Versus Ambu AuraGain LM in Children

S

Schulthess Klinik

Status

Unknown

Conditions

Airway Management

Treatments

Device: Ambu AuraOnce
Device: Ambu AuraGain

Study type

Interventional

Funder types

Other

Identifiers

NCT02811042
Schulthess_Anä_7

Details and patient eligibility

About

The investigators test the hypothesis that oropharyngeal leak pressure and fiberoptic position differ between the size 2 LM Ambu AuraOnce and the LM Ambu AuraGain in non-paralyzed anaesthetized pediatric patients.

Enrollment

60 estimated patients

Sex

All

Ages

1 to 16 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ASA I-II
  • age 1 - 16 years
  • minor surgery
  • extraglottic airway device

Exclusion criteria

  • age (<12 months, >16 years)
  • weight (<12 kg, >50 kg)
  • a known difficult airway
  • risk of aspiration

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

60 participants in 2 patient groups

Oropharyngeal leak pressure
Active Comparator group
Description:
Ambu AuraOnce
Treatment:
Device: Ambu AuraOnce
Fiberoptic position
Experimental group
Description:
Ambu AuraGain
Treatment:
Device: Ambu AuraGain

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems